295 related articles for article (PubMed ID: 15772144)
1. Activity of histone H1.2 in infected burn wounds.
Jacobsen F; Baraniskin A; Mertens J; Mittler D; Mohammadi-Tabrisi A; Schubert S; Soltau M; Lehnhardt M; Behnke B; Gatermann S; Steinau HU; Steinstraesser L
J Antimicrob Chemother; 2005 May; 55(5):735-41. PubMed ID: 15772144
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.
Jacobsen F; Mohammadi-Tabrisi A; Hirsch T; Mittler D; Mygind PH; Sonksen CP; Raventos D; Kristensen HH; Gatermann S; Lehnhardt M; Daigeler A; Steinau HU; Steinstraesser L
J Antimicrob Chemother; 2007 Mar; 59(3):493-8. PubMed ID: 17289767
[TBL] [Abstract][Full Text] [Related]
3. The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity.
Zhou H; Dou J; Wang J; Chen L; Wang H; Zhou W; Li Y; Zhou C
Peptides; 2011 Jun; 32(6):1131-8. PubMed ID: 21515321
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infected wounds with the antimicrobial peptide D2A21.
Chalekson CP; Neumeister MW; Jaynes J
J Trauma; 2003 Apr; 54(4):770-4. PubMed ID: 12707542
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds.
Björn C; Noppa L; Näslund Salomonsson E; Johansson AL; Nilsson E; Mahlapuu M; Håkansson J
Int J Antimicrob Agents; 2015 May; 45(5):519-24. PubMed ID: 25649371
[TBL] [Abstract][Full Text] [Related]
6. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of a pig-derived peptide antibiotic on porcine wound infections.
Ceccarelli AV; Cole AM; Park AK; Tahk S; Yoshioka D; Ganz T
Comp Med; 2001 Feb; 51(1):75-9. PubMed ID: 11926306
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.
Ostorhazi E; Holub MC; Rozgonyi F; Harmos F; Cassone M; Wade JD; Otvos L
Int J Antimicrob Agents; 2011 May; 37(5):480-4. PubMed ID: 21353493
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
[TBL] [Abstract][Full Text] [Related]
11. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
Ziółkowski G; Dudzińska G; Sakiel S
Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
[No Abstract] [Full Text] [Related]
12. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
[TBL] [Abstract][Full Text] [Related]
13. Gr-1(+)CD11b(+) cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice.
Kobayashi M; Yoshida T; Takeuchi D; Jones VC; Shigematsu K; Herndon DN; Suzuki F
J Leukoc Biol; 2008 Jun; 83(6):1354-62. PubMed ID: 18372338
[TBL] [Abstract][Full Text] [Related]
14. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses.
Willcox MD; Hume EB; Aliwarga Y; Kumar N; Cole N
J Appl Microbiol; 2008 Dec; 105(6):1817-25. PubMed ID: 19016975
[TBL] [Abstract][Full Text] [Related]
15. Short Synthetic β-Sheet Antimicrobial Peptides for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Burn Wound Infections.
Zhong G; Cheng J; Liang ZC; Xu L; Lou W; Bao C; Ong ZY; Dong H; Yang YY; Fan W
Adv Healthc Mater; 2017 Apr; 6(7):. PubMed ID: 28135045
[TBL] [Abstract][Full Text] [Related]
16. Di-K19Hc, an antimicrobial peptide as new ototopical agent for treatment of otitis media.
Lee YS; Kim YJ; Choi SH; Shin KH; Jang WS; Lee IH; Chung JW
Acta Otolaryngol; 2010 Aug; 130(8):897-903. PubMed ID: 20100130
[TBL] [Abstract][Full Text] [Related]
17. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1.
Frecer V
Bioorg Med Chem; 2006 Sep; 14(17):6065-74. PubMed ID: 16714114
[TBL] [Abstract][Full Text] [Related]
18. Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel).
Chalekson CP; Neumeister MW; Jaynes J
Plast Reconstr Surg; 2002 Apr; 109(4):1338-43. PubMed ID: 11964988
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation.
Simonetti O; Cirioni O; Lucarini G; Orlando F; Ghiselli R; Silvestri C; Brescini L; Rocchi M; Provinciali M; Guerrieri M; Di Primio R; Giacometti A; Offidani A
J Antimicrob Chemother; 2012 Jan; 67(1):191-201. PubMed ID: 22065244
[TBL] [Abstract][Full Text] [Related]
20. [A mixture of antimicrobial peptides and fibrin glue in treatment of partial-thickness burn wounds].
Lahoda LU; Wang SC; Vogt PM
Chirurg; 2006 Mar; 77(3):251-6. PubMed ID: 16208508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
